424 related articles for article (PubMed ID: 11245774)
1. The genetics and physiology of polycystic kidney disease.
Calvet JP; Grantham JJ
Semin Nephrol; 2001 Mar; 21(2):107-23. PubMed ID: 11245774
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetics of polycystic kidney disease.
Calvet JP
J Nephrol; 1998; 11(1):24-34. PubMed ID: 9561482
[TBL] [Abstract][Full Text] [Related]
3. Pkd2 Deficiency in Embryonic Aqp2 + Progenitor Cells Is Sufficient to Cause Severe Polycystic Kidney Disease.
Tsilosani A; Gao C; Chen E; Lightle AR; Shehzad S; Sharma M; Tran PV; Bates CM; Wallace DP; Zhang W
J Am Soc Nephrol; 2024 Apr; 35(4):398-409. PubMed ID: 38254271
[TBL] [Abstract][Full Text] [Related]
4. Molecular and cellular pathogenesis of autosomal dominant polycystic kidney disease.
Bastos AP; Onuchic LF
Braz J Med Biol Res; 2011 Jul; 44(7):606-17. PubMed ID: 21625823
[TBL] [Abstract][Full Text] [Related]
5. Polycystins, calcium signaling, and human diseases.
Delmas P; Padilla F; Osorio N; Coste B; Raoux M; Crest M
Biochem Biophys Res Commun; 2004 Oct; 322(4):1374-83. PubMed ID: 15336986
[TBL] [Abstract][Full Text] [Related]
6. Polycystin-1 transforms the cAMP growth-responsive phenotype of M-1 cells.
Sutters M; Yamaguchi T; Maser RL; Magenheimer BS; St John PL; Abrahamson DR; Grantham JJ; Calvet JP
Kidney Int; 2001 Aug; 60(2):484-94. PubMed ID: 11473631
[TBL] [Abstract][Full Text] [Related]
7. Multidrug therapy for polycystic kidney disease: a review and perspective.
Aguiari G; Catizone L; Del Senno L
Am J Nephrol; 2013; 37(2):175-82. PubMed ID: 23428809
[TBL] [Abstract][Full Text] [Related]
8. The etiology, pathogenesis, and treatment of autosomal dominant polycystic kidney disease: recent advances.
Grantham JJ
Am J Kidney Dis; 1996 Dec; 28(6):788-803. PubMed ID: 8957030
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
Ishimoto Y; Inagi R; Yoshihara D; Kugita M; Nagao S; Shimizu A; Takeda N; Wake M; Honda K; Zhou J; Nangaku M
Mol Cell Biol; 2017 Dec; 37(24):. PubMed ID: 28993480
[TBL] [Abstract][Full Text] [Related]
10. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).
Boucher C; Sandford R
Eur J Hum Genet; 2004 May; 12(5):347-54. PubMed ID: 14872199
[TBL] [Abstract][Full Text] [Related]
11. Adenylyl cyclase 5 links changes in calcium homeostasis to cAMP-dependent cyst growth in polycystic liver disease.
Spirli C; Mariotti V; Villani A; Fabris L; Fiorotto R; Strazzabosco M
J Hepatol; 2017 Mar; 66(3):571-580. PubMed ID: 27826057
[TBL] [Abstract][Full Text] [Related]
12. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells.
Belibi FA; Reif G; Wallace DP; Yamaguchi T; Olsen L; Li H; Helmkamp GM; Grantham JJ
Kidney Int; 2004 Sep; 66(3):964-73. PubMed ID: 15327388
[TBL] [Abstract][Full Text] [Related]
13. Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator/Na(+),K(+),2Cl(-) Co-transporter-dependent cystic dilation.
Magenheimer BS; St John PL; Isom KS; Abrahamson DR; De Lisle RC; Wallace DP; Maser RL; Grantham JJ; Calvet JP
J Am Soc Nephrol; 2006 Dec; 17(12):3424-37. PubMed ID: 17108316
[TBL] [Abstract][Full Text] [Related]
14. Molecular advances in autosomal dominant polycystic kidney disease.
Gallagher AR; Germino GG; Somlo S
Adv Chronic Kidney Dis; 2010 Mar; 17(2):118-30. PubMed ID: 20219615
[TBL] [Abstract][Full Text] [Related]
15. Polycystin-2 regulates proliferation and branching morphogenesis in kidney epithelial cells.
Grimm DH; Karihaloo A; Cai Y; Somlo S; Cantley LG; Caplan MJ
J Biol Chem; 2006 Jan; 281(1):137-44. PubMed ID: 16278216
[TBL] [Abstract][Full Text] [Related]
16. Polycystins: polymodal receptor/ion-channel cellular sensors.
Delmas P
Pflugers Arch; 2005 Oct; 451(1):264-76. PubMed ID: 15889307
[TBL] [Abstract][Full Text] [Related]
17. Mutant polycystin-2 induces proliferation in primary rat tubular epithelial cells in a STAT-1/p21-independent fashion accompanied instead by alterations in expression of p57KIP2 and Cdk2.
Felekkis KN; Koupepidou P; Kastanos E; Witzgall R; Bai CX; Li L; Tsiokas L; Gretz N; Deltas C
BMC Nephrol; 2008 Aug; 9():10. PubMed ID: 18721488
[TBL] [Abstract][Full Text] [Related]
18. Autosomal dominant polycystic kidney disease: Disrupted pathways and potential therapeutic interventions.
Malekshahabi T; Khoshdel Rad N; Serra AL; Moghadasali R
J Cell Physiol; 2019 Aug; 234(8):12451-12470. PubMed ID: 30644092
[TBL] [Abstract][Full Text] [Related]
19. New insights into polycystic kidney disease and its treatment.
Torres VE
Curr Opin Nephrol Hypertens; 1998 Mar; 7(2):159-69. PubMed ID: 9529618
[TBL] [Abstract][Full Text] [Related]
20. Autosomal dominant polycystic kidney disease: clues to pathogenesis.
Harris PC
Hum Mol Genet; 1999; 8(10):1861-6. PubMed ID: 10469838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
